Integrated Proteins Ratios

Integrated Proteins Ltd Ratios

The Integrated Proteins Ltd Ratios page provides a complete fundamental analysis of Integrated Proteins Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Integrated Proteins Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Integrated Proteins Ltd (NSE: , BSE: 519606) is currently trading at ₹37.42, with a market capitalization of ₹0. As a major player in the Process industries sector and Agricultural commodities/Milling industry, Integrated Proteins Ltd remains a key stock for fundamental analysis using Integrated Proteins Ltd Ratios.

Integrated Proteins Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Integrated Proteins Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Integrated Proteins Ltd Ratios.

Historically, the Integrated Proteins Ltd P/E ratio has shown strong fluctuations:

The decline in Integrated Proteins Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Integrated Proteins Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.

Historical P/B trend:

Integrated Proteins Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Integrated Proteins Ltd P/S ratio currently stands at 0, an important part of Integrated Proteins Ltd Ratios for revenue valuation.

Historical P/S ratio:

A stable or declining Integrated Proteins Ltd P/S ratio indicates cautious market sentiment.

Integrated Proteins Ltd Price to Cash Flow Ratio (P/CF)

The Integrated Proteins Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Integrated Proteins Ltd Price to Cash Flow Ratio:

The declining Integrated Proteins Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Integrated Proteins Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Integrated Proteins Ltd EV currently stands at ₹0, representing the total company valuation including debt.

Historical EV trend:

Integrated Proteins Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Integrated Proteins Ltd EV/EBITDA ratio is currently 0, a key metric in Integrated Proteins Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

Stable Integrated Proteins Ltd EV/EBITDA indicates balanced valuation.

Integrated Proteins Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Integrated Proteins Ltd D/E ratio is currently 0, reflecting leverage and financial stability.

Historical D/E:

Integrated Proteins Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Integrated Proteins Ltd ROE currently stands at 0%, showing profitability and capital efficiency.

Historical ROE:

Declining ROE indicates pressure on profitability.

Integrated Proteins Ltd Ratios Analysis Summary

The Integrated Proteins Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Integrated Proteins Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Integrated Proteins Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.